hec pharm-星力游戏官方网

product name

standard

strength

packing size

status

amlodipine besylate

film-coated tablet

usp

2.5/5/10mg

90s x 1

global marketing

in-house

5/10mg

10s x 1

azithromycin 1h₂o

film-coated tablet

usp

250/500/600mg

30s x 1

us under review

azithromycin 2h₂o

film-coated tablet

in-house

250mg

500mg

6s x 1

3s x 1

global marketing

ciprofloxacin

film-coated tablet

in-house

100/250/500/750mg

10s x 1

global marketing

clarithromycin

film-coated tablet

usp

250mg/500mg

60s x 1

global marketing

in-house

250mg

500mg

5s x3

7sx2/6, 10sx2

clarithromycin

extended-release  tablet

usp

500mg

10s x 1

global marketing

in-house

500mg

10s x 1/2/10

entacapone

film-coated tablet

usp

200mg

60s x 1

global marketing

in-house

200mg

30s x 1

esomeprazole magnesium delayed-release capsules

usp

in-house

20/40mg

60s x 1

eu approving in 2017

fingolimod capsules

in-house

0.5mg

7s x 1/4

us under review

ibuprofen

film-coated  tablet

usp

400/600/800mg

100/60/50s x 1

us under review

irbesartan

film-coated  tablet

usp  

75/150

300mg

30/90s x 1

30s x 1

global marketing

in-house

75/150/300mg

6s x 1

levofloxacin

film-coated  tablet

usp

250/500/750mg

50/50/20s x 1

global marketing

in-house

250/500mg

6/10s x 1

linagliptin  tablets

in-house

5mg

30s x 1

us under review

linagliptin and metformin  hydrochloride tablets

in-house

2.5mg/500mg 

2.5mg/850mg

2.5mg/1000mg

60s x 1

us under review

metformin tablets

usp

500/850/1000

1000s x 1

us under review

moxifloxacin hcl

film-coated  tablet

usp

400mg

30s x 1

global marketing

in-house

400mg

10s x 1

sitagliptin and metformin film-coated  tablet

in-house

50/850mg; 50/1000mg

14/60 x 1

eu approving in 2017

olanzapine

film-coated  tablet

usp

2.5/5/7.5/10/15/20mg

30s x 1

global marketing

in-house

2.5/5/7.5/10/15/20mg

7/10s x 1

olanzapine

orally  disintegrating tablets

usp

5/10/15/20mg

30s x 1

global marketing

in-house

5/10/15/20mg

10s x 1

olmesartan medoxomil

tablets

in-house

10 /20 /40 mg

7/10s x 1

eu approving in 2017

prasugrel hcl

film-coated  tablet

in-house

5/10mg

30s x 1

us under review

rivaroxaban tablets

in-house

10/15/20mg

30s x 1, 90s x 1

us under review

simvastatin

film-coated tablet

usp

5/10/20/40/80mg

30s x 1

us under review

ticagrelor  tablets

in-house

90mg

60s x 1

us under review

zidovudine

film-coated  tablet

usp

300mg

60s x 1

global marketing

product name

dosage form

standard

strength

packing size

status

azithromycin

capsules

cp

250 mg

6s × 1/2

marketed

azithromycin

dispersible tablets

cp

250 mg

6s × 1/2

marketed

azithromycin

suspension

cp

100 mg

6s, 8s, 12s

marketed

amlodipine besylate

tablets

cp

5 mg

7s, 14s, 28s

marketed

benzbromarone

tablets

cp

50 mg

10s

marketed

cetirizine hydrochloride

dispersible tablets

cp

10 mg

6s × 1/2/4

marketed

clarithromycin

dispersible tablets

cp

250 mg

6s

marketed

clarithromycin

tablets

cp

250 mg

6s

marketed

fluconazole

capsules

cp

50 mg

6s, 10s

marketed

fudosteine

tablets

cp

200mg

6s× 2

marketed

glipizide

capsules

cp

5mg

10s × 3

marketed

levofloxacin lactate

tablets

cp

100 mg

10s

marketed

lisinopril

tablets

cp

10 mg

7s × 1/2/4

marketed

mycophenolate mofetil

powder for injection

cp

500mg

2s

marketed

oxaprozin

enteric-coated tablets

cp

200 mg

8s × 1/2/3

marketed

ozagrel sodium

powder for injection

cp

20mg

8s

marketed

simvastatin

tablets

cp

10 mg

10s

marketed

20 mg

7s × 1/2

marketed

telmisartan

tablets

cp

40 mg,80 mg

7s × 1/2

marketed

valacyclovir  hydrochloride

tablets

cp

300 mg

6s, 10s

marketed